Perrigo Operating Expenses 2010-2024 | PRGO

Perrigo operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Perrigo Annual Operating Expenses
(Millions of US $)
2023 $4,504
2022 $4,373
2021 $3,728
2020 $3,823
2019 $3,695
2018 $4,495
2017 $4,348
2016 $7,280
2015 $2,565
2015 $3,555
2014 $3,343
2013 $2,861
2012 $2,604
2011 $2,265
2010 $1,932
2009 $1,756
Perrigo Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $1,007
2024-06-30 $1,092
2024-03-31 $1,137
2023-12-31 $1,173
2023-09-30 $1,062
2023-06-30 $1,136
2023-03-31 $1,133
2022-12-31 $1,124
2022-09-30 $1,067
2022-06-30 $1,129
2022-03-31 $1,053
2021-12-31 $1,058
2021-09-30 $604
2021-06-30 $1,107
2021-03-31 $959
2020-12-31 $1,016
2020-09-30 $925
2020-06-30 $886
2020-03-31 $997
2019-12-31 $392
2019-09-30 $1,137
2019-06-30 $1,094
2019-03-31 $1,072
2018-12-31 $1,088
2018-09-30 $1,255
2018-06-30 $1,092
2018-03-31 $1,061
2017-12-31 $1,125
2017-09-30 $1,069
2017-06-30 $1,089
2017-03-31 $1,066
2016-12-31 $1,816
2016-09-30 $2,730
2016-06-30 $1,156
2016-03-31 $1,579
2015-12-31 $-533
2015-09-30 $1,098
2015-06-30 $1,223
2015-03-31 $777
2014-12-31
2014-09-30 $814
2014-06-30
2014-03-31 $901
2013-12-31
2013-09-30 $754
2013-06-30
2013-03-31 $741
2012-12-31
2012-09-30 $613
2012-06-30
2012-03-31 $632
2011-12-31
2011-09-30 $624
2011-06-30
2011-03-31 $569
2010-12-31
2010-09-30 $530
2010-06-30
2010-03-31 $448
2009-12-31
2009-09-30 $442
2009-06-30
2009-03-31 $434
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.547B $4.656B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.757B 25.10
Stryker (SYK) United States $136.750B 30.82
Boston Scientific (BSX) United States $131.731B 37.87
EssilorLuxottica (ESLOY) France $109.710B 0.00
Medtronic (MDT) Ireland $102.865B 15.28
Haleon (HLN) United Kingdom $42.732B 27.76
Lonza Group Ag (LZAGY) Switzerland $42.382B 0.00
GE HealthCare Technologies (GEHC) United States $35.810B 18.57
ResMed (RMD) United States $33.540B 27.56
Terumo (TRUMY) Japan $28.681B 40.51
Koninklijke Philips (PHG) Netherlands $23.480B 17.97
Zimmer Biomet Holdings (ZBH) United States $20.795B 13.24
Insulet (PODD) United States $18.017B 71.75
Baxter (BAX) United States $14.940B 9.72
Smith & Nephew SNATS (SNN) United Kingdom $10.667B 0.00
BellRing Brands (BRBR) United States $9.606B 38.65
Bio-Rad Laboratories (BIO) United States $9.131B 31.03
Demant (WILYY) Denmark $8.251B 0.00
Lantheus Holdings (LNTH) United States $6.174B 14.35
Haemonetics (HAE) United States $3.938B 19.22
ICU Medical (ICUI) United States $3.868B 36.83
Prestige Consumer Healthcare (PBH) United States $3.840B 19.10
Envista Holdings (NVST) United States $3.289B 24.50
QuidelOrtho (QDEL) United States $3.029B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.863B 18.36
Neogen (NEOG) United States $2.587B 29.85
LeMaitre Vascular (LMAT) United States $2.057B 49.98
Green Thumb Industries (GTBIF) United States $1.724B 30.17
AtriCure (ATRC) United States $1.482B 0.00
InMode (INMD) Israel $1.424B 8.57
Maravai LifeSciences Holdings (MRVI) United States $1.386B 0.00
AdaptHealth (AHCO) United States $1.305B 9.33
BioLife Solutions (BLFS) United States $1.214B 0.00
Curaleaf Holdings (CURLF) Canada $1.066B 0.00
Owens & Minor (OMI) United States $0.991B 7.74
CeriBell (CBLL) United States $0.926B 0.00
Phibro Animal Health (PAHC) United States $0.840B 14.81
Evolus (EOLS) United States $0.704B 0.00
Capricor Therapeutics (CAPR) United States $0.680B 0.00
VAREX IMAGING (VREX) United States $0.594B 26.20
Omeros (OMER) United States $0.570B 0.00
Surmodics (SRDX) United States $0.567B 0.00
Verano Holdings (VRNOF) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.463B 0.00
Quanterix (QTRX) United States $0.415B 0.00
Valneva SE (VALN) France $0.384B 0.00
ZimVie (ZIMV) United States $0.382B 32.16
Biote (BTMD) United States $0.328B 7.18
Viemed Healthcare (VMD) United States $0.317B 30.11
Canopy Growth (CGC) Canada $0.314B 0.00
Cerus (CERS) United States $0.292B 0.00
Sanara MedTech (SMTI) United States $0.289B 0.00
High Tide (HITI) Canada $0.269B 110.67
OraSure Technologies (OSUR) United States $0.264B 17.70
Zynex (ZYXI) United States $0.249B 52.07
Aurora Cannabis (ACB) Canada $0.247B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.208B 14.37
MacroGenics (MGNX) United States $0.207B 0.00
TerrAscend (TSNDF) Canada $0.205B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.180B 95.80
TriSalus Life Sciences (TLSI) United States $0.152B 0.00
Jin Medical (ZJYL) China $0.149B 0.00
FitLife Brands (FTLF) United States $0.148B 18.59
Quipt Home Medical (QIPT) United States $0.125B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.095B 0.00
InterCure (INCR) Israel $0.072B 0.00
Rockwell Medical (RMTI) United States $0.072B 37.00
Jushi Holdings (JUSHF) United States $0.065B 0.00
Ayr Wellness (AYRWF) United States $0.060B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Exagen (XGN) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Safety Shot (SHOT) United States $0.045B 0.00
Allurion Technologies (ALUR) United States $0.027B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Nephros (NEPH) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.84
SNDL (SNDL) Canada $0.000B 0.00